Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.

@article{Khan2003SuicideRI,
  title={Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.},
  author={A. Khan and S. Khan and R. Kolts and W. Brown},
  journal={The American journal of psychiatry},
  year={2003},
  volume={160 4},
  pages={
          790-2
        }
}
  • A. Khan, S. Khan, +1 author W. Brown
  • Published 2003
  • Psychology, Medicine
  • The American journal of psychiatry
  • OBJECTIVE Previous reports suggesting that selective serotonin reuptake inhibitor (SSRI) use is associated with increased suicidal risk have not assessed completed suicides. The authors analyzed reports from randomized controlled trials to compare suicide rates among depressed patients assigned to an SSRI, other antidepressants, or placebo. METHOD Food and Drug Administration (FDA) summary reports of the controlled clinical trials for nine modern FDA-approved antidepressants provided data for… CONTINUE READING
    Duloxetine: Meta-analyses of Suicidal Behaviors and Ideation in Clinical Trials for Major Depressive Disorder
    • 53
    • Highly Influenced
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 11 REFERENCES